Search

everythinglearnresearchcommunity

for

Search:↓

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Finasteride reduces prostate size and PSA levels in young patients.

Low doses of Coffea arabica seed extract prevent prostate growth and lower uric acid and PSA levels.

Early baldness in men may indicate a higher risk of prostate cancer.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Early balding may be a sign of future prostate problems.

Urinary PSA could be an early marker for enlarged prostate.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The compound was successfully made and shows potential for treating prostate cancer.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Shorter PSADT after prostate surgery is linked to higher risk of death.